PAK1 and hepatocellular carcinoma: Consistently, we reported in this paper that PAK1 activity (pPAK1 level) was positively correlated with the IC50 values of Sorafenib in a cell proliferation assay, indicating a role of PAK1 in HCC resistance to Sorafenib.